Viewing Study NCT00017303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-13 @ 4:08 PM
Study NCT ID: NCT00017303
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 2001-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Sponsor: Cytran
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III ovarian epithelial cancer View
None ovarian undifferentiated adenocarcinoma View
None ovarian mixed epithelial carcinoma View
None ovarian serous cystadenocarcinoma View
None ovarian mucinous cystadenocarcinoma View
None ovarian endometrioid adenocarcinoma View
None ovarian clear cell cystadenocarcinoma View
None primary peritoneal cavity cancer View
None Brenner tumor View